Magnus Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 7.00 Cr
- Paid Up Capital ₹ 7.00 Cr
- Company Age 3 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 14.19 Cr
- Revenue Growth %
- Profit Growth 200.89%
- Ebitda 294.99%
- Net Worth 4804101.37%
- Total Assets 355.19%
About Magnus Life Sciences
Magnus Life Sciences Private Limited (MLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 October 2021 (Three years and three months 22 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.00 Cr and a paid-up capital of Rs 7.00 Cr.
The company currently has active open charges totaling ₹14.19 Cr.
Rahul Peddi and Joji Tera serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24230TG2021PTC156325
-
Company No.
156325
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Oct 2021
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Magnus Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rahul Peddi
|
Director | 25-Oct-2021 | Current |
|
Joji Tera
|
Director | 25-Oct-2021 | Current |
Financial Performance of Magnus Life Sciences.
Magnus Life Sciences Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 200.89% increase in profit. The company's net worth Soared by an impressive increase of 4804101.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Magnus Life Sciences?
In 2023, Magnus Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Kria Ventures Private LimitedRahul Peddi is a mutual person
Charges (Loans)
₹14.19 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 12.05 Cr
- Others : 2.14 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Nov 2024 | Others | ₹1.96 Cr | Open |
| 26 May 2023 | Others | ₹0.94 M | Open |
| 24 Feb 2023 | Others | ₹0.84 M | Open |
| 07 Sep 2022 | State Bank Of India | ₹12.05 Cr | Open |
How Many Employees Work at Magnus Life Sciences?
Unlock and access historical data on people associated with Magnus Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Magnus Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Magnus Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.